| CASE REPORT |
|
| Year : 2011 | Volume
: 18
| Issue : 3 | Page : 243-245 |
|
|
Response of diabetic papillopathy to intravitreal bevacizumab
Hassan Al-Dhibi, Arif O Khan
King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
Correspondence Address:
Arif O Khan
King Khaled Eye Specialist Hospital, PO Box 7191, Riyadh 11462
Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-9233.84056
|
|
|
Diabetic papillopathy is an uncommon hyperemic optic disc swelling that occurs in patients with long-standing diabetes, is typically self-resolving with minimal effect on vision, and is likely ischemic in origin. The purpose of the current report is to document the response of diabetic papillopathy to intravitreal injection of bevacizumab (Avastin, Genentech Inc, San Francisco, California, USA), a humanized monoclonal antibody to vascular endothelial growth factor. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
